This image is not available for purchase in your country.

Regorafenib cancer drug

Regorafenib cancer drug

C049/3599

Rights Managed

20.8 MB (3.1 MB compressed)

3304 x 2202 pixels

27.9 x 18.5 cm ⏐ 11.0 x 7.3 in (300dpi)

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

DR P. MARAZZI / SCIENCE PHOTO LIBRARY DR P. MARAZZI / SCIENCE PHOTO LIBRARY

Restrictions

Editorial use only.

Caption

Regorafenib cancer drug capsule. This drug, marketed as Stivarga, is a multi-kinase inhibitor used to treat metastatic colorectal cancer, advanced hepatocellular carcinoma and advanced gastrointestinal stromal tumours. It blocks a number of cell signaling molecules (kinases) and prevents cell proliferation and the growth of new blood vessels (angiogenesis) to the cancer.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Calculate price
  • Add to board